ABEO

2.4201.22%
FL

Faith L. Charles

Independent Chairman of Board

Ms. Faith L. Charles, JD, is Senior Advisor of Audaz Capital. She is Partner of Thompson Hine LLP. She serves as an Independent Director since June 22, 2026 at Curaleaf Holdings, Inc. She is Independent Interim Chairman of the Board of Abeona Therapeutics Inc. and is its Independent Director from March 26, 2021. She is Director of Agilvax, Inc. She served as an Independent Director at Conduit Pharmaceuticals Inc. (Formerly, Murphy Canyon Acquisition Corp.) since September 2023 until April 16, 2025. She is Director of Sandstone Diagnostics, Inc. She is Independent Director of Avenue Therapeutics, Inc. from May 16, 2022. She is Independent Chairman of Board of CNS Pharmaceuticals, Inc. from December 30, 2022. She was Director of Amydis, Inc. until January 2023. She was employed at Amydis, Inc. until January 2023. She serves as Partner in Corporate Transactions & Securities Practice Group at Thompson Hine LLP since 2010. She has been Director at Amydis Diagnostics, Inc. She serves as outside counsel to a myriad of life sciences companies and is known in the industry as an astute business advisor, providing valuable insights into capital markets, corporate governance and strategic development. She has handled a variety of complex corporate transactions including public and private equity and debt financings, private placements, public offerings, corporate governance, mergers and acquisitions, joint ventures and strategic alliances and venture capital financing both domestically and internationally. Ms. Charles also has experience representing biotechnology and medical device companies in matters related to technology licensing transactions, sponsored research, follow-on offerings, PIPE financing and assisting public companies in going private. Primary industries of her clients have included public and private start-ups and late-stage companies, underwriters and placement agents, as well as life science, biotechnology, internet and high technology companies, wholesale, retail and investment banking companies. She serves as Director of Agilvax, Inc. Since 2018, Ms. Charles served as Director at Entera Bio Ltd since 2018 until October 2021. Ms. Charles founded the Women in Bio Metro New York chapter and chaired the chapter. She serves on the national Board of Women in Bio. Ms. Charles is also a Member of the Board of Gilda Club New York City (now Red Door Community). She has been recognized as a Life Sciences Star by Euromoney LMG Life Sciences, has been named a BTI Client Service All-Star in 2006 and 2007 and was named by Crain New York Business to the list of 2020 Notable Women in the Law. She served as Member of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. She is a Member of Association of the Bar of the City of New York. Ms. Charles holds a J.D. from George Washington University Law Center in 1986 and B.A. in Psychology from Barnard College, Columbia University in 1983. Ms. Charles is a graduate of Women in Bio Boardroom Ready Program, an Executive Education Program taught by The George Washington University School of Business.

Positions